Article(id=1325225168523637625, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225021030932569, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.04.017, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1772467200000, receivedDateStr=2026-03-03, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887901668, onlineDateStr=2026-11-05, pubDate=1775750400000, pubDateStr=2026-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887901668, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887901668, creator=13701087609, updateTime=1793887901668, updator=13701087609, issue=Issue{id=1325225021030932569, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='4', pageStart='377', pageEnd='498', issueExtLink='null', onlineDate='null', pubDate='1775750400000', pubDateStr='2026-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887866504, creator='13701087609', updateTime=1793946144656, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325469457388273914, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225021030932569, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325469457388273915, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325225021030932569, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=494, endPage=498, ext={EN=ArticleExt(id=1325225168724964219, articleId=1325225168523637625, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Feasibility Study on Rare Disease Sector as a Strategic Pivot for Innovative Drug Development in China from the Perspective of Industrial Management, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Jianhui LIU, Yufeng MAO*, authorsList=Jianhui LIU, Yufeng MAO, authorCompany=null, correspAuthors=Yufeng MAO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325225168926290812, articleId=1325225168523637625, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=产业管理视角下罕见病领域作为中国创新药战略支点的可行性研究, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

我国创新药正处于从“仿创结合”迈向“源头创新”的关键转型期。为同时提升研发效率、降低试错成本,并实现能力外溢,产业政策与企业战略亟须探索合理的措施与路径。文章从产业管理视角出发,系统分析了中国罕见病领域的现状、挑战与独特价值,通过剖析产业价值链、评估政策环境,论证了将罕见病领域作为我国创新药发展战略支点的可行性。该研究认为,罕见病领域具有临床研发效率较高、监管支持明确、市场独占性强、能牵引前沿技术等特点,可成为实现差异化竞争、积累研发原始创新能力,并最终向常见病领域拓展的关键跳板。同时,从产业规划、生态构建、社会保障等方面提出了系统性建议,以期为中国创新药的战略转型提供一定的理论参考。

, authors=刘健惠, 茅喻丰*, authorsList=刘健惠, 茅喻丰, authorCompany=null, correspAuthors=茅喻丰, authorNote=

刘健惠,高级工程师,从事医药政策市场及战略研究。

, correspAuthorsNote=
茅喻丰,工程师,从事医药市场战略研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=OmJ0NoDDjBiZhjGQcyyLag==, magXml=LMHGG7f8ZySSenwNX+icqA==, pdfUrl=null, pdf=/KU0cJv8z9692F6xwq/LzA==, pdfFileSize=945790, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=1txx4SicGqQqFxC/tPl+rA==, mapNumber=null, fund=null)}, authors=[Author(id=1325225169274418049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225169345721219, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, authorId=1325225169274418049, language=EN, stringName=Jianhui LIU, firstName=Jianhui, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225169421218692, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, authorId=1325225169274418049, language=CN, stringName=刘健惠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海现代制药营销有限公司,上海 200050, bio={"content":"

刘健惠,高级工程师,从事医药政策市场及战略研究。

"}, bioImg=null, bioContent=

刘健惠,高级工程师,从事医药政策市场及战略研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225169127617405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, xref=null, ext=[AuthorCompanyExt(id=1325225169136006014, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050), AuthorCompanyExt(id=1325225169140200319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海现代制药营销有限公司,上海 200050)])]), Author(id=1325225169496716166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225169601573768, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, authorId=1325225169496716166, language=EN, stringName=Yufeng MAO, firstName=Yufeng, middleName=null, lastName=MAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225169681265545, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, authorId=1325225169496716166, language=CN, stringName=茅喻丰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海现代制药营销有限公司,上海 200050, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225169127617405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, xref=null, ext=[AuthorCompanyExt(id=1325225169136006014, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050), AuthorCompanyExt(id=1325225169140200319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海现代制药营销有限公司,上海 200050)])])], keywords=[Keyword(id=1325225169781928842, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, language=CN, orderNo=1, keyword=罕见病), Keyword(id=1325225169849037707, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, language=CN, orderNo=2, keyword=创新药), Keyword(id=1325225169932923788, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, language=CN, orderNo=3, keyword=产业管理), Keyword(id=1325225170004226957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, language=CN, orderNo=4, keyword=生物医药), Keyword(id=1325225170075530126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, language=CN, orderNo=5, keyword=研发战略)], refs=[Reference(id=1325225170176193424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=沙利文. 2025中国罕见病行业趋势观察报告[EB/OL]. (2025-02-28)[2025-12-07]. https://www.frostchina.com/content/insight/detail/67bed1ec7ed30cc08c184b97., articleTitle=null, refAbstract=null), Reference(id=1325225170251690897, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=弓孟春, 郭艳英, 郑熙弘, 等. 中国罕见病分级诊疗体系建设中的信息化系统考量[J]. 罕见病研究, 2024, 3(4):527-534., articleTitle=null, refAbstract=null), Reference(id=1325225170318799762, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=张 文, 闫晓婷, 许 莹, 等. 罕见病研究数据采集和应用的现状及伦理学思考[J]. 中国医学伦理学, 2023, 36(10):1132-1137., articleTitle=null, refAbstract=null), Reference(id=1325225170398491539, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=郭 健, 刘 鹏, 荆志成, 等. 中国国家罕见病注册系统建设及应用[J]. 罕见病研究, 2022, 1(1):7-12., articleTitle=null, refAbstract=null), Reference(id=1325225170465600404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=周 奇, 李沁原, 刘雅莉, 等. 罕见病指南的制订:现状、挑战与机遇[J]. 协和医学杂志, 2023, 14(3):621-628., articleTitle=null, refAbstract=null), Reference(id=1325225170532709269, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=关于公布第一批罕见病目录的通知[J]. 中华人民共和国国家卫生健康委员会公报, 2018, (5):15-19., articleTitle=null, refAbstract=null), Reference(id=1325225172315288470, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=中华人民共和国中央人民政府. 关于公布第二批罕见病目录的通知[EB/OL]. (2025-02-01)[2025-12-07]. https://www.gov.cn/zhengce/zhengceku/202309/content_6905273.htm., articleTitle=null, refAbstract=null), Reference(id=1325225172394980247, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=新华社. 图表:超100种!我国医保罕见病用药数量创新高[EB/OL]. (2025-12-16)[2025-02-01]. https://www.gov.cn/zhengce/jiedu/tujie/202512/content_7051887.htm., articleTitle=null, refAbstract=null), Reference(id=1325225172470477720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心. 2024年度药品审评报告[EB/OL]. https://www.cde.org.cn/main/news/viewInfoCommon/54538c67b7e764fc51666567fc620241., articleTitle=null, refAbstract=null), Reference(id=1325225172533392281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心. 国家药监局药审中心发布《中国新药注册临床试验进展年度报告(2024年)》[EB/OL]. [2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/d0bc4836cfc4cb7c9ecf29ddaa7be6ea., articleTitle=null, refAbstract=null), Reference(id=1325225172604695450, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=罕见病信息网. 35种罕见病药物在我国获批上市!中国速度领跑全球 | 年终盘点[EB/OL]. (2026-01-01)[2025-02-01]. https://mp.weixin.qq.com/s/ELg3FkZ9ja-P2CvxO262hA., articleTitle=null, refAbstract=null), Reference(id=1325225172692775835, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=桂俊峰. 罕见病诊疗现状及发展展望[J]. 临床医学进展,2024, 14(4):681-688., articleTitle=null, refAbstract=null), Reference(id=1325225172759884700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=上海市浦东新区科技和经济委员会. 创新成果、创新举措、创新服务,2025张江药谷产业生态全球推介会都有哪些亮点?[EB/OL]. [2025-02-01]. https://www.pudong.gov.cn/019010005/20251013/815390.html., articleTitle=null, refAbstract=null), Reference(id=1325225172826993565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO Z Y, PEI Z Y, HU A X, et al. Analysis of incentive policies and initiatives on orphan drug development in China:challenges, reforms and implications [J]. Orphanet J Rare Dis, 2023, 18(1):220., articleTitle=null, refAbstract=null), Reference(id=1325225172898296734, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=全国罕见病学术团体联席会议. 中国罕见病定义研究报告(2021) [EB/OL]. (2021-09-11)[2025-02-01]. https://www.docin.com/p-2987644561.html., articleTitle=null, refAbstract=null), Reference(id=1325225172986377119, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药监局药审中心. 国家药监局药审中心关于发布《罕见疾病药物临床研发技术指导原则》的通告[EB/OL]. (2021-12-31)[2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/c4e1ef312a0a0c039a7a4ca55b91d4e8., articleTitle=null, refAbstract=null), Reference(id=1325225173070263200, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药监局药审中心. 国家药监局药审中心关于发布《罕见疾病药物临床研究统计学指导原则(试行)》的通告[EB/OL]. (2022-06-02)[2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/058e0d665b785e79b7f4f24dc1dc970c., articleTitle=null, refAbstract=null), Reference(id=1325225173175120801, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药监局药审中心. 国家药监局药审中心关于发布《在罕见疾病药物临床研发中应用去中心化临床试验的技术指导原则》的通告[EB/OL]. (2024-05-28)[2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/e5b3409ea38fbc8254bb0635d004c73d., articleTitle=null, refAbstract=null), Reference(id=1325225173309338530, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药监局药审中心. 国家药监局药审中心关于发布《以患者为中心的罕见疾病药物研发试点工作计划(“关爱计划”)》的通知[EB/OL]. (2024-09-13)[2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/244dc3661a418359aa12d7cba9bacf5d., articleTitle=null, refAbstract=null), Reference(id=1325225173397418915, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=PENG A, FAN X, ZOU L, et al. Trend of clinical trials of new drugs for rare diseases in China in recent 10 years [J]. Orphanet J Rare Dis, 2023, 18(1):114., articleTitle=null, refAbstract=null), Reference(id=1325225173481304996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=TAMBUYZER E, VANDENDRIESSCHE B, AUSTIN C P,et al. Therapies for rare diseases:therapeutic modalities,progress and challenges ahead [J]. Nat Rev Drug Discov,2020, 19(2):93-111., articleTitle=null, refAbstract=null), Reference(id=1325225173552608165, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=雪球. 中国创新药行业全景报告(2025):政策、技术、产业链与核心企业深度解析[EB/OL]. (2025-11-19)[2025-02-01]. https://xueqiu.com/1363095930/362298569., articleTitle=null, refAbstract=null), Reference(id=1325225173636494246, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=QIAN T, ZHENG B, LIU R R, et al. Efficacy and safety of BRL-101 in TDT and SCD [EB/OL]. [2025-02-01]. https://library.ehaweb.org/eha/2025/eha2025-congress/4159367/tan.qian.efficacy.and.safety.of.brl-101.in.tdt.and.scd.html., articleTitle=null, refAbstract=null), Reference(id=1325225173720380327, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=摩熵咨询. 2025全球罕见病行业发展报告:政策演进、市场趋势与领先企业布[EB/OL]. [2025-02-01]. https://pdf.dfcfw.com/pdf/H3_AP202601281818514005_1.pdf?1769635872000.pdf., articleTitle=null, refAbstract=null), Reference(id=1325225173795877800, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=国家医保局, 国家卫生健康委. 国家医保局 国家卫生健康委关于建立完善国家医保谈判药品“双通道”管理机制的指导意见[EB/OL]. (2021-04-22)[2025-02-01]. https://www.gov.cn/zhengce/zhengceku/202105/10/content_5605595.htm., articleTitle=null, refAbstract=null), Reference(id=1325225173883958185, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=克里斯・安德森. 长尾理论 [M]. 乔江涛, 石晓燕, 译. 北京:中信出版社, 2006., articleTitle=null, refAbstract=null), Reference(id=1325225173972038570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Mordor Intelligence. Orphan drugs market size & share analysis - growth trends and forecast(2025—2031) [EB/OL]. [2025-02-01]. https://www.mordorintelligence.com/industry-reports/orphan-drugs-market., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325225169127617405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, xref=null, ext=[AuthorCompanyExt(id=1325225169136006014, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050), AuthorCompanyExt(id=1325225169140200319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海现代制药营销有限公司,上海 200050)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.04.017, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.04.017, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.04.017, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.04.017, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1775750400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
产业管理视角下罕见病领域作为中国创新药战略支点的可行性研究
刘健惠 , 茅喻丰 *
中国医药工业杂志 | 药学管理与信息 2026,57(4): 494-498
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2026 , 57 (4) : 494 -498
产业管理视角下罕见病领域作为中国创新药战略支点的可行性研究
全屏
[Author(id=1325225169274418049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225169345721219, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, authorId=1325225169274418049, language=EN, stringName=Jianhui LIU, firstName=Jianhui, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225169421218692, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, authorId=1325225169274418049, language=CN, stringName=刘健惠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海现代制药营销有限公司,上海 200050, bio={"content":"

刘健惠,高级工程师,从事医药政策市场及战略研究。

"}, bioImg=null, bioContent=

刘健惠,高级工程师,从事医药政策市场及战略研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225169127617405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, xref=null, ext=[AuthorCompanyExt(id=1325225169136006014, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050), AuthorCompanyExt(id=1325225169140200319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海现代制药营销有限公司,上海 200050)])]), Author(id=1325225169496716166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225169601573768, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, authorId=1325225169496716166, language=EN, stringName=Yufeng MAO, firstName=Yufeng, middleName=null, lastName=MAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225169681265545, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, authorId=1325225169496716166, language=CN, stringName=茅喻丰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海现代制药营销有限公司,上海 200050, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225169127617405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, xref=null, ext=[AuthorCompanyExt(id=1325225169136006014, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050), AuthorCompanyExt(id=1325225169140200319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225168523637625, companyId=1325225169127617405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海现代制药营销有限公司,上海 200050)])])]
刘健惠, 茅喻丰*
作者信息
  • 上海现代制药营销有限公司,上海 200050
通讯作者:
茅喻丰,工程师,从事医药市场战略研究。
作者简介:

刘健惠,高级工程师,从事医药政策市场及战略研究。

Feasibility Study on Rare Disease Sector as a Strategic Pivot for Innovative Drug Development in China from the Perspective of Industrial Management
Jianhui LIU, Yufeng MAO*
Affiliations
  • Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050
出版时间: 2026-04-10 doi: 10.16522/j.cnki.cjph.2026.04.017
文章导航
收藏切换

我国创新药正处于从“仿创结合”迈向“源头创新”的关键转型期。为同时提升研发效率、降低试错成本,并实现能力外溢,产业政策与企业战略亟须探索合理的措施与路径。文章从产业管理视角出发,系统分析了中国罕见病领域的现状、挑战与独特价值,通过剖析产业价值链、评估政策环境,论证了将罕见病领域作为我国创新药发展战略支点的可行性。该研究认为,罕见病领域具有临床研发效率较高、监管支持明确、市场独占性强、能牵引前沿技术等特点,可成为实现差异化竞争、积累研发原始创新能力,并最终向常见病领域拓展的关键跳板。同时,从产业规划、生态构建、社会保障等方面提出了系统性建议,以期为中国创新药的战略转型提供一定的理论参考。

罕见病  /  创新药  /  产业管理  /  生物医药  /  研发战略
刘健惠, 茅喻丰. 产业管理视角下罕见病领域作为中国创新药战略支点的可行性研究. 中国医药工业杂志, 2026 , 57 (4) : 494 -498 . DOI: 10.16522/j.cnki.cjph.2026.04.017
Jianhui LIU, Yufeng MAO. Feasibility Study on Rare Disease Sector as a Strategic Pivot for Innovative Drug Development in China from the Perspective of Industrial Management[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (4) : 494 -498 . DOI: 10.16522/j.cnki.cjph.2026.04.017

参考文献 引证文献
排序方式:
[1]
沙利文. 2025中国罕见病行业趋势观察报告[EB/OL]. (2025-02-28)[2025-12-07]. https://www.frostchina.com/content/insight/detail/67bed1ec7ed30cc08c184b97.
[2]
弓孟春, 郭艳英, 郑熙弘, 等. 中国罕见病分级诊疗体系建设中的信息化系统考量[J]. 罕见病研究, 2024, 3(4):527-534.
[3]
张 文, 闫晓婷, 许 莹, 等. 罕见病研究数据采集和应用的现状及伦理学思考[J]. 中国医学伦理学, 2023, 36(10):1132-1137.
[4]
郭 健, 刘 鹏, 荆志成, 等. 中国国家罕见病注册系统建设及应用[J]. 罕见病研究, 2022, 1(1):7-12.
[5]
周 奇, 李沁原, 刘雅莉, 等. 罕见病指南的制订:现状、挑战与机遇[J]. 协和医学杂志, 2023, 14(3):621-628.
[6]
关于公布第一批罕见病目录的通知[J]. 中华人民共和国国家卫生健康委员会公报, 2018, (5):15-19.
[7]
中华人民共和国中央人民政府. 关于公布第二批罕见病目录的通知[EB/OL]. (2025-02-01)[2025-12-07]. https://www.gov.cn/zhengce/zhengceku/202309/content_6905273.htm.
[8]
新华社. 图表:超100种!我国医保罕见病用药数量创新高[EB/OL]. (2025-12-16)[2025-02-01]. https://www.gov.cn/zhengce/jiedu/tujie/202512/content_7051887.htm.
[9]
国家药品监督管理局药品审评中心. 2024年度药品审评报告[EB/OL]. https://www.cde.org.cn/main/news/viewInfoCommon/54538c67b7e764fc51666567fc620241.
[10]
国家药品监督管理局药品审评中心. 国家药监局药审中心发布《中国新药注册临床试验进展年度报告(2024年)》[EB/OL]. [2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/d0bc4836cfc4cb7c9ecf29ddaa7be6ea.
[11]
罕见病信息网. 35种罕见病药物在我国获批上市!中国速度领跑全球 | 年终盘点[EB/OL]. (2026-01-01)[2025-02-01]. https://mp.weixin.qq.com/s/ELg3FkZ9ja-P2CvxO262hA.
[12]
桂俊峰. 罕见病诊疗现状及发展展望[J]. 临床医学进展,2024, 14(4):681-688.
[13]
上海市浦东新区科技和经济委员会. 创新成果、创新举措、创新服务,2025张江药谷产业生态全球推介会都有哪些亮点?[EB/OL]. [2025-02-01]. https://www.pudong.gov.cn/019010005/20251013/815390.html.
[14]
ZHAO Z Y, PEI Z Y, HU A X, et al. Analysis of incentive policies and initiatives on orphan drug development in China:challenges, reforms and implications [J]. Orphanet J Rare Dis, 2023, 18(1):220.
[15]
全国罕见病学术团体联席会议. 中国罕见病定义研究报告(2021) [EB/OL]. (2021-09-11)[2025-02-01]. https://www.docin.com/p-2987644561.html.
[16]
国家药监局药审中心. 国家药监局药审中心关于发布《罕见疾病药物临床研发技术指导原则》的通告[EB/OL]. (2021-12-31)[2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/c4e1ef312a0a0c039a7a4ca55b91d4e8.
[17]
国家药监局药审中心. 国家药监局药审中心关于发布《罕见疾病药物临床研究统计学指导原则(试行)》的通告[EB/OL]. (2022-06-02)[2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/058e0d665b785e79b7f4f24dc1dc970c.
[18]
国家药监局药审中心. 国家药监局药审中心关于发布《在罕见疾病药物临床研发中应用去中心化临床试验的技术指导原则》的通告[EB/OL]. (2024-05-28)[2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/e5b3409ea38fbc8254bb0635d004c73d.
[19]
国家药监局药审中心. 国家药监局药审中心关于发布《以患者为中心的罕见疾病药物研发试点工作计划(“关爱计划”)》的通知[EB/OL]. (2024-09-13)[2025-02-01]. https://www.cde.org.cn/main/news/viewInfoCommon/244dc3661a418359aa12d7cba9bacf5d.
[20]
PENG A, FAN X, ZOU L, et al. Trend of clinical trials of new drugs for rare diseases in China in recent 10 years [J]. Orphanet J Rare Dis, 2023, 18(1):114.
[21]
TAMBUYZER E, VANDENDRIESSCHE B, AUSTIN C P,et al. Therapies for rare diseases:therapeutic modalities,progress and challenges ahead [J]. Nat Rev Drug Discov,2020, 19(2):93-111.
[22]
雪球. 中国创新药行业全景报告(2025):政策、技术、产业链与核心企业深度解析[EB/OL]. (2025-11-19)[2025-02-01]. https://xueqiu.com/1363095930/362298569.
[23]
QIAN T, ZHENG B, LIU R R, et al. Efficacy and safety of BRL-101 in TDT and SCD [EB/OL]. [2025-02-01]. https://library.ehaweb.org/eha/2025/eha2025-congress/4159367/tan.qian.efficacy.and.safety.of.brl-101.in.tdt.and.scd.html.
[24]
摩熵咨询. 2025全球罕见病行业发展报告:政策演进、市场趋势与领先企业布[EB/OL]. [2025-02-01]. https://pdf.dfcfw.com/pdf/H3_AP202601281818514005_1.pdf?1769635872000.pdf.
[25]
国家医保局, 国家卫生健康委. 国家医保局 国家卫生健康委关于建立完善国家医保谈判药品“双通道”管理机制的指导意见[EB/OL]. (2021-04-22)[2025-02-01]. https://www.gov.cn/zhengce/zhengceku/202105/10/content_5605595.htm.
[26]
克里斯・安德森. 长尾理论 [M]. 乔江涛, 石晓燕, 译. 北京:中信出版社, 2006.
[27]
Mordor Intelligence. Orphan drugs market size & share analysis - growth trends and forecast(2025—2031) [EB/OL]. [2025-02-01]. https://www.mordorintelligence.com/industry-reports/orphan-drugs-market.
2026年第57卷第4期
120
31
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2026.04.017
  • 接收时间:2026-03-03
  • 首发时间:2026-11-05
  • 出版时间:2026-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2026-03-03
基金
作者信息
    上海现代制药营销有限公司,上海 200050

通讯作者:

茅喻丰,工程师,从事医药市场战略研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.04.017
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏